Clinical Trials Browser

Completed × Acetylcarnitine × Plasma cell × Clear all

NCT00581919 2019-12-13

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

Phase 2 Completed

32 enrolled 8 charts

Multiple Myeloma